| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.8M | -33.6% |
| Cost of Revenue | $3.3M | -51.7% |
| Gross Profit | $6.5M | -17.9% |
| R&D Expense | $42K | -38.2% |
| SG&A Expense | $7.4M | +16.6% |
| Operating Income | -$5.8M | +23.1% |
| Income Tax | $0 | — |
| Net Income | -$7.2M | +25.1% |
| EPS (Basic) | -$2.53 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $430K | -86.3% |
| Inventory | $765K | -73.4% |
| Current Assets | $1.9M | -73.0% |
| Total Assets | $3.4M | -62.1% |
| Current Liabilities | $2.8M | -33.5% |
| Total Liabilities | $3.6M | -37.9% |
| Stockholders' Equity | -$129K | -103.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $6K | -68.4% |
| Investing Cash Flow | $1.1M | +5700.0% |
| Financing Cash Flow | $1.5M | -21.5% |
| +36.1% |